Niquitin (Nicotine)

Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By stimulating these receptors, it mimics the effect of tobacco‑derived nicotine, decreasing withdrawal intensity and craving, thereby facilitating gradual reduction of nicotine intake.

The specific dose and duration of Niquitin are determined by the prescribing health‑care professional based on the individual’s smoking history, level of dependence, and prior quit attempts. The prescriber selects the appropriate patch strength and schedule.

Safety of nicotine patches during pregnancy or lactation has not been established. Because nicotine can cross the placenta and enter breast milk, use is generally discouraged unless the potential benefit outweighs the risk and is approved by a qualified clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with nicotine gum or lozenges, the transdermal patch provides a steady, controlled release of nicotine over 16–24 hours, which can improve adherence and reduce peaks and troughs in blood nicotine levels. It is also convenient as it requires only once‑daily application, whereas gums and lozenges need multiple doses throughout the day.

Store Niquitin at room temperature, below 25 °C, in its original sealed pouch. Keep the patch away from direct sunlight, moisture and heat sources. Do not expose to temperatures above the recommended range, and keep out of reach of children.

The patch is applied to a clean, dry, hair‑free area of the upper body or upper outer arm. Press firmly for several seconds, ensuring full contact. Replace the patch according to the prescriber’s schedule, typically every 16–24 hours, and rotate application sites to avoid skin irritation.

Serious adverse reactions, though uncommon, include severe skin allergic responses, hypotension, chest pain, and dizziness that may indicate cardiovascular effects. Users should seek immediate medical attention if they experience any signs of an allergic reaction, unexplained chest discomfort, or faintness.

Niquitin is contraindicated in individuals who are not currently smokers, those with known hypersensitivity to nicotine or patch adhesives, and patients with recent myocardial infarction, unstable angina, or severe cardiac arrhythmias. It should also be avoided in pregnant or breastfeeding women unless specifically advised by a qualified health professional.